Latest News & Updates | Lymphoma Canada Announcements

Research

Ontario funds rituximab for the treatment of relapsed Chronic Lymphocytic Leukemia (CLL)

Lymphoma Canada applauds the Ontario government for its decision to expand the funding criteria for…

adminJune 10, 2013

Research

Canadian Provinces Fund New Treatment for patients with indolent non-Hodgkin’s Lymphoma (iNHL) and Mantle Cell Lymphoma (MCL)

Lymphoma Canada applauds the recent reimbursement announcements by the provinces of Alberta, Saskatchewan and Ontario…

adminMay 29, 2013

News

Healthy mind, body, and soul

It is said time and time again. Diet and exercise is important. Studies suggest that…

adminMay 8, 2013

News

LC celebrates with a blast from the past

Lymphoma Canada started the year off with a fundraiser at the Paul-Émile-Lépine Community Centre, where…

adminMay 8, 2013

News

One day dedicated to Information, help, and hope

Be sure to mark September 15th on your calendars. That day is World Lymphoma Awareness…

adminMay 8, 2013

News

The High Price Tag of an Innovative Treatment

The innovative drug ADCETRIS was approved for sale by Health Canada this past February.

adminMay 8, 2013

News

Treatment through positivity

When Hayley Holroyd looked into the mirror, she saw a healthy woman. It was not…

adminMay 8, 2013

Press Releases

Provincial drug plans adding new lymphoma treatment is good news for patients, but other promising cancer therapies still awaiting green light

TORONTO, April 24, 2013 /CNW/ - The recent approval by Health Canada of a highly…

adminMay 3, 2013

Press Releases

Lymphoma Foundation Canada announces name change and launch of new brand

TORONTO – April 29, 2013 Lymphoma Foundation Canada (LFC) has changed its name, logo and…

adminApril 29, 2013

Research

Obinutuzumab (GA101) Significantly Improved Progression-Free Survival in People With Chronic Lymphocytic Leukemia (CLL)

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive…

adminApril 25, 2013

Mon	Tue	Wed	Thu	Fri	Sat	Sun
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

News & Media

Ontario funds rituximab for the treatment of relapsed Chronic Lymphocytic Leukemia (CLL)

Canadian Provinces Fund New Treatment for patients with indolent non-Hodgkin’s Lymphoma (iNHL) and Mantle Cell Lymphoma (MCL)

Healthy mind, body, and soul

LC celebrates with a blast from the past

One day dedicated to Information, help, and hope

The High Price Tag of an Innovative Treatment

Treatment through positivity

Provincial drug plans adding new lymphoma treatment is good news for patients, but other promising cancer therapies still awaiting green light

Lymphoma Foundation Canada announces name change and launch of new brand

Obinutuzumab (GA101) Significantly Improved Progression-Free Survival in People With Chronic Lymphocytic Leukemia (CLL)

Are you a patient?

Are you a healthcare professional?

Upcoming Events

Contact Us

Donate

Careers

Join Our Mailing List